drug
safusidenib
Phase 3updated 5mo agoby $NUVB Nuvation Bio Inc.
Phase 3community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying safusidenib
- phase2Safusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II Study
- phase2Safety and Efficacy Study of Safusidenib in Participants With IDH1-Mutant Glioma Who Discontinued Vorasidenib Treatment Due to Progressive Disease
- phase3SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- EP1A Study of AB-218 in Patients With IDH1 Mutated Low Grade Glioma
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that